Company: HRTX
Filing Date: 2025-10-15
Form Type: 8-K
Source: 0001193125-25-240253
Chunk: 2

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-10-15
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                           
      No.                                                                                                            
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                              Heron Therapeutics, Inc.                           
  Date: October 15, 2025      /s/ Ira Duarte                                     
                              Ira Duarte                                         
                              Executive Vice President, Chief Financial Officer